Free Trial

Bruker (BRKR) Stock Forecast & Price Target

Bruker logo
$57.00 +1.71 (+3.09%)
(As of 12/20/2024 05:51 PM ET)

Bruker - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
5
Buy
7

Based on 12 Wall Street analysts who have issued ratings for Bruker in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 5 have given a hold rating, and 7 have given a buy rating for BRKR.

Consensus Price Target

$74.45
30.62% Upside
According to the 12 analysts' twelve-month price targets for Bruker, the average price target is $74.45. The highest price target for BRKR is $90.00, while the lowest price target for BRKR is $60.00. The average price target represents a forecasted upside of 30.62% from the current price of $57.00.
Get the Latest News and Ratings for BRKR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Bruker and its competitors.

Sign Up

BRKR Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
2 Buy rating(s)
Hold
5 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$74.45$79.36$81.40$80.00
Forecasted Upside30.62% Upside39.06% Upside21.20% Upside8.52% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold

BRKR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BRKR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Bruker Stock vs. The Competition

TypeBrukerComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.58
2.69
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside30.62% Upside265.04% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent BRKR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/19/2024Guggenheim
2 of 5 stars
S. Nambi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$72.00+30.01%
12/13/2024Bank of America
3 of 5 stars
 Boost TargetBuy ➝ Buy$78.00 ➝ $80.00+40.06%
12/10/2024UBS Group
4 of 5 stars
J. Sourbeer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Neutral$102.00 ➝ $66.00+7.40%
12/5/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Sykes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$60.00 ➝ $60.00+0.84%
11/6/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$80.00 ➝ $75.00+24.56%
11/6/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$72.00 ➝ $70.00+17.69%
This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.
11/6/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$78.00 ➝ $75.00+26.31%
11/6/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Sergott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$75.00 ➝ $69.00+12.49%
9/30/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
6/3/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$85.00+28.55%
5/20/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$81.00 ➝ $77.00+2.57%
2/14/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$60.00 ➝ $90.00+17.20%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:30 AM ET.


BRKR Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Bruker is $74.45, with a high forecast of $90.00 and a low forecast of $60.00.

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BRKR shares.

According to analysts, Bruker's stock has a predicted upside of 30.62% based on their 12-month stock forecasts.

Over the previous 90 days, Bruker's stock had 1 upgrade and 1 downgrade by analysts.

Bruker has been rated by research analysts at Bank of America, Barclays, Citigroup, Guggenheim, TD Cowen, The Goldman Sachs Group, UBS Group, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Bruker less than other "computer and technology" companies. The consensus rating score for Bruker is 2.58 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how BRKR compares to other companies.


This page (NASDAQ:BRKR) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners